LDL-lowering therapy, statins, PCSK9 inhibitors, and primary and secondary cardiovascular prevention trials from The Rhythm.
Lipids & Prevention
Issue 22 | Week of 1 September 2026 ESC Congress 2026 is taking place in Munich this week, running from 28 to 31 August, one of the largest Hot Line weeks in the meeting's recent history. This issue covers papers first published on 28 and 29 August; papers first
Lipids & Prevention
Issue 20 | Week of 17th August 2026 No major cardiology congress fell this week. The strongest evidence came from The Lancet Healthy Longevity, JACC's special issue on obesity, JAMA Cardiology, and the European Heart Journal. Cardiology Intelligence Briefing: the trouble with average Cardiovascular evidence keeps hitting the same
Heart Failure
Issue 9 | Week of 1 June 2026 No major general cardiology congress fell in this window, and the week's most-discussed evidence arrived mainly through journal publication, including two early-phase platform studies in the New England Journal of Medicine. Cardiology Intelligence Briefing: the distance between promise and